A 6-week Dose Ranging Study of CHF 5259 pMDI in Subjects With Chronic Obstructive Pulmonary Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

733

Participants

Timeline

Start Date

July 28, 2017

Primary Completion Date

May 23, 2018

Study Completion Date

June 6, 2018

Conditions
COPDChronic Obstructive Pulmonary Disease
Interventions
DRUG

CHF 5259

Dose Response: Test one of four different doses of CHF 5259

DRUG

Placebo

Placebo Control

DRUG

Tiotropium Bromide 18 µg Inhalation Capsule

Active Control

Trial Locations (112)

10455

Chiesi Investigational Site, The Bronx

19140

Chiesi Investigational Site, Philadelphia

21093

Chiesi Investigational Site, Lutherville

23225

Chiesi Investigational Site, Richmond

27103

Chiesi Investigational Site, Winston-Salem

27607

Chiesi Investigational Site, Raleigh

28054

Chiesi Investigational Site, Gastonia

28117

Chiesi Investigational Site, Mooresville

28150

Chiesi Investigational Site, Shelby

28207

Chiesi Investigational Site, Charlotte

28401

Chiesi Investigational Site, Wilmington

28739

Chiesi Investigational Site, Hendersonville

29118

Chiesi Investigational Site, Orangeburg

29303

Chiesi Investigational Site, Spartanburg

29340

Chiesi Investigational Site, Gaffney

29379

Chiesi Investigational Site, Union

29406

Chiesi Investigational Site, Charleston

29464

Chiesi Investigational Site, Mt. Pleasant

29615

Chiesi Investigational Site, Greenville

29621

Chiesi Investigational Site, Anderson

29640

Chiesi Investigational Site, Easley

29678

Chiesi Investigational Site, Seneca

29707

Chiesi Investigational Site, Fort Mill

29732

Chiesi Investigational Site, Rock Hill

30019

Chiesi Investigational Site, Dacula

30046

Chiesi Investigational Site, Lawrenceville

30060

Chiesi Investigational Site, Marietta

30096

Chiesi Investigational Site, Duluth

30513

Chiesi Investigational Site, Blue Ridge

31405

Chiesi Investigational Site, Savannah

32117

Chiesi Investigational Site, Daytona Beach

32132

Chiesi Investigational Site, Edgewater

32405

Chiesi Investigational Site, Panama City

32825

Chiesi Investigational Site, Orlando

33012

Chiesi Investigational Site, Hialeah

33144

Chiesi Investigational Site, Miami

33165

Chiesi Investigational Site, Miami

33176

Chiesi Investigational Site, Miami

33186

Chiesi Investigational Site, Miami

33511

Chiesi Investigational Site, Brandon

33765

Chiesi Investigational Site, Clearwater

34741

Chiesi Investigational Site, Kissimmee

35244

Chiesi Investigational Site, Birmingham

36106

Chiesi Investigational Site, Montgomery

36305

Chiesi Investigational Site, Dothan

37067

Chiesi Investigational Site, Franklin

37388

Chiesi Investigational Site, Tullahoma

37909

Chiesi Investigational Site, Knoxville

38305

Chiesi Investigational Site, Jackson

40215

Chiesi Investigational Site, Louisville

40218

Chiesi Investigational Site, Louisville

43123

Chiesi Investigational Site, Grove City

43213

Chiesi Investigational Site, Columbus

43215

Chiesi Investigational Site, Columbus

45242

Chiesi Investigational Site, Cincinnati

45409

Clinical Research Solutions, Dayton

46383

Chiesi Investigational Site, Valparaiso

47714

Chiesi Investigational Site, Evansville

48106

Chiesi Investigational Site, Ann Arbor

48336

Chiesi Investigational Site, Farmington Hills

55402

Chiesi Investigational Site, Minneapolis

57702

Chiesi Investigational Site, Rapid City

59808

Chiesi Investigational Site, Missoula

60607

Chiesi Investigational Site, Chicago

63141

Chiesi Investigational Site, St Louis

63301

Chiesi Investigational Site, Saint Charles

68114

Chiesi Investigational Site, Omaha

70526

Chiesi Investigational Site, Crowley

70601

Chiesi Investigational Site, Lake Charles

73034

Chiesi Investigational Site, Edmond

73103

Chiesi Investigational Site, Oklahoma City

75092

Chiesi Investigational Site, Sherman

77375

Chiesi Investigational Site, Tomball

77429

Chiesi Investigational Site, Cypress

78006

Chiesi Investigational Site, Boerne

78130

Chiesi Investigational Site, New Braunfels

80026

Chiesi Investigational Site, Lafayette

80112

Chiesi Investigational Site, Centennial

80230

Chiesi Investigational Site, Denver

80301

Chiesi Investigational Site, Boulder

85006

Chiesi Investigational Site, Phoenix

85014

Chiesi Investigational Site, Phoenix

85018

Chiesi Investigational Site, Phoenix

85283

Chiesi Investigational Site, Tempe

85306

Chiesi Investigational Site, Glendale

85374

Chiesi Investigational Site, Surprise

85710

Chiesi Investigational Site, Tucson

86001

Chiesi Investigational Site, Flagstaff

87108

Chiesi Investigational Site, Albuquerque

89119

Chiesi Investigational Site, Las Vegas

90017

Chiesi Investigational Site, Los Angeles

90036

Chiesi Investigational Site, Los Angeles

90048

Chiesi Investigational Site, Los Angeles

90806

Chiesi Investigational Site, Long Beach

92025

Chiesi Investigational Site, Escondido

92120

Chiesi Investigational Site, San Diego

92663

Chiesi Investigational Site, Newport Beach

92683

Chiesi Investigational Site, Westminster

92780

Chiesi Investigational Site, Tustin

92801

Chiesi Investigational Site, Anaheim

92835

Chiesi Investigational Site, Fullerton

95648

Clinical Trials Research, Lincoln

97202

Chiesi Investigational Site, Portland

97504

Chiesi Investigational Site, Medford

98208

Chiesi Investigational Site, Everett

98405

Chiesi Investigational Site, Tacoma

99352

Chiesi Investigational Site, Richland

02720

Chiesi Investigational Site, Fall River

02721

Chiesi Investigational Site, Fall River

07901

Chiesi Investigational Site, Summit

02914

Chiesi Investigational Site, East Providence

05403

Chiesi Investigational Site, South Burlington

All Listed Sponsors
lead

Chiesi Farmaceutici S.p.A.

INDUSTRY

NCT03084796 - A 6-week Dose Ranging Study of CHF 5259 pMDI in Subjects With Chronic Obstructive Pulmonary Disease | Biotech Hunter | Biotech Hunter